Bangor, United States
BioSpectra Inc. (BSI) is a privately-owned manufacturer of premium pharmaceutical ingredients and bulk, cGMP fine chemicals, based in the United States. Established in 1994, the company serves numerous leading BioPharma companies globally. With a focus on innovative purification and synthetic capabilities, BSI specializes in the production of finished cGMP products that enhance the drug manufacturing process at various stages.
As a leader in cGMP manufacturing, BSI's portfolio encompasses bulk GMP biological buffers, GMP Buffer Solutions, GMP process fine-chemicals, and new chemical entities (NCEs) produced at IPEC & ICH Q7 regulatory compliance levels. The company's expertise lies in small molecule synthesis and phase-change multi-step purification, offering solutions for diverse cGMP key ingredient issues throughout the drug manufacturing process.
Although no recent investment details are available, BSI continues to position itself as a reliable and innovative partner for BioPharma industry players, demonstrating its commitment to manufacturing excellence and regulatory compliance.
